Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000211690 | SCV000295079 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Cardiovascular Research Group, |
RCV000211690 | SCV000599352 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | curation | |
Kasturba Medical College, |
RCV000211690 | SCV005088709 | pathogenic | Hypercholesterolemia, familial, 1 | criteria provided, single submitter | clinical testing | In-silico tools (Human Splicing Finder and Splice AI) are consistent in predicting to alter the acceptor splice site which may lead to aberrant splicing leading to either the formation of a truncated protein or the transcript to undergo nonsense-mediated mRNA decay. This variant present at a consensus splice site is reported to cause intron inclusion without evidence of degradation of the mutant transcripts (Holla ØL et al., 2009). This variant is reported in the ClinVar database with pathogenic/likely pathogenic interpretation in three independent submissions (ClinVar ID: 226340). The clinical features observed in the proband and her similarly affected sibling are in concordance with hypercholesterolemia, familial, 1. | |
Cardiovascular Genetics Laboratory, |
RCV000211690 | SCV000268592 | pathogenic | Hypercholesterolemia, familial, 1 | 2015-12-11 | no assertion criteria provided | clinical testing |